Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland
1. Alvotech acquires Ivers-Lee Group, enhancing assembly and packaging capacity. 2. Ivers-Lee will integrate operations into Alvotech's Technical Operations division. 3. Three new biosimilars are scheduled for launch in 2025. 4. The acquisition provides flexibility to meet global biosimilar demand. 5. Ivers-Lee's facilities are GMP licensed and FDA approved.